AEON Biopharma presents ABP-450 biosimilar data at headache conference Jun 4, 2026 07:03AM
AEON Biopharma (AEON) Misses Q1 EPS by 29c May 15, 2026 06:02AM
AEON Biopharma receives second NYSE American listing notice Apr 6, 2026 05:54AM
AEON Biopharma (AEON) files for 51.29M share offering by selling stockholders Feb 9, 2026 04:44PM
AEON Biopharma completes $15 million debt exchange with Daewoong Jan 21, 2026 04:09PM


Jan 21, 2026 04:05PM AEON Biopharma holds FDA meeting, gets shareholder approval for financing
Dec 15, 2025 04:05PM AEON Biopharma signs debt exchange deal with Daewoong
Nov 14, 2025 04:27PM AEON Biopharma (AEON) Misses Q3 EPS by 39c
Nov 14, 2025 08:30AM AEON Biopharma reports ABP-450 biosimilar data ahead of FDA meeting
Apr 25, 2025 04:05PM AEON Biopharma (AEON) Announces NYSE American Acceptance of Plan to Regain Listing Compliance
Apr 21, 2025 04:05PM AEON Biopharma (AEON) Appoints Rob Bancroft as CEO
Mar 27, 2025 04:05PM AEON Biopharma (AEON) Announces CEO Change
Feb 24, 2025 02:01PM AEON Biopharma (AEON) Announces 1:72 Reverse Share Split
Feb 7, 2025 04:05PM AEON Biopharma (AEON) Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Jan 6, 2025 09:03AM AEON Biopharma (AEON) Prices 40M Unit Offering at $0.50/unit
Oct 1, 2024 07:07AM H.C. Wainwright Reiterates Buy Rating on AEON Biopharma, Inc (AEON)
Sep 30, 2024 08:03AM AEON Biopharma (AEON) Announces Positive Outcome from FDA Biosimilar Advisory Meeting
Aug 15, 2024 06:26AM AEON Biopharma (AEON) Files $200M Mixed Shelf
Aug 14, 2024 06:43AM AEON Biopharma, Inc (AEON) PT Lowered to $5 at H.C. Wainwright
Jul 10, 2024 08:34AM H.C. Wainwright Reiterates Buy Rating on AEON Biopharma, Inc (AEON)